Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
Liang K, Feliciano JL, Marrone KA, Murray JC, Hann CL, Anagnostou V, Tackett SA, Shin EJ, Hales RK, Voong KR, Battafarano RJ, Yang SC, Broderick SR, Ha JS, Forde PM, Brahmer JR, Lam VK. Liang K, et al. Among authors: voong kr. ESMO Open. 2024 Jan;9(1):102199. doi: 10.1016/j.esmoop.2023.102199. Epub 2023 Dec 9. ESMO Open. 2024. PMID: 38071928 Free PMC article.
Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.
Hoffman KE, Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen Q, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA. Hoffman KE, et al. Among authors: voong kr. J Clin Oncol. 2018 Oct 10;36(29):2943-2949. doi: 10.1200/JCO.2018.77.9868. Epub 2018 Aug 14. J Clin Oncol. 2018. PMID: 30106637 Free PMC article. Clinical Trial.
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial.
Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Hoffman KE, et al. Among authors: voong kr. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1074-84. doi: 10.1016/j.ijrobp.2014.01.015. Int J Radiat Oncol Biol Phys. 2014. PMID: 24661661 Clinical Trial.
Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapy.
Guo W, Hui X, Alfaifi S, Anderson L, Robertson S, Hales R, Hu C, McNutt T, Broderick S, Naidoo J, Battafarano R, Yang S, Voong KR. Guo W, et al. Among authors: voong kr. Pract Radiat Oncol. 2018 Jul-Aug;8(4):e239-e248. doi: 10.1016/j.prro.2018.01.004. Epub 2018 Jan 31. Pract Radiat Oncol. 2018. PMID: 29960625
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J. Suresh K, et al. Among authors: voong kr. J Thorac Oncol. 2018 Dec;13(12):1930-1939. doi: 10.1016/j.jtho.2018.08.2035. Epub 2018 Sep 26. J Thorac Oncol. 2018. PMID: 30267842 Free article.
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.
Suresh K, Psoter KJ, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Naidoo J. Suresh K, et al. Among authors: voong kr. J Thorac Oncol. 2019 Mar;14(3):494-502. doi: 10.1016/j.jtho.2018.11.016. Epub 2018 Nov 30. J Thorac Oncol. 2019. PMID: 30503891 Free article.
59 results